Amply Discovery
Amply Discovery is a startup headquartered in Belfast, United Kingdom, founded in 2021. It has won about £851k in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Amply Discovery has won about £851k in competitive Innovate UK grants since 2023.
- Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets. (£100k, 2024)
- Preclinical validation of evolution-designed, AI-discovered, synthetically printed biologic molecules for Chronic and MDR Lower Respiratory Tract Infections (£100k, 2024)
- Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML). (£379k, 2024)
- Discovery and preclinical validation of evolution-designed, AI-discovered, synthetically printed biologic molecules for MDR-TB (£272k, 2023)
R&D ecosystem
Amply Discovery sits inside the Belfast R&D ecosystem in the Global R&D Labs Directory.
Other startups in Belfast
Related
- Innovation profile of Belfast
- United Kingdom: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Amply Discovery do?
Amply Discovery works in biotechnology. Its Innovate UK projects include: Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets..
Where is Amply Discovery based?
Amply Discovery is headquartered in Belfast, United Kingdom.
When was Amply Discovery founded?
Amply Discovery was founded in 2021.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.